Pharmacodia
PrivateLast Round
Series C
Apr 18, 2019
Total Funding Raised
$32.62M
Company Overview
Pharmacodia operates in Enterprise Software and is based in Beijing. Its latest recorded funding round was a Series C round in April 2019.
Pharmacodia is an enterprise systems company that provides a global database and information platform for pharmaceutical research and development.
Sector
Enterprise Software
Verticals
Business Intelligence, Drug Discovery, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmacodia Comparables
Compare Pharmacodia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmCube | 89% | |
| Yaozhi Group | 86% | |
| Yaorongyun Digital Technology | 84% |
For institutional investors. Book with your work email.
Pharmacodia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 18, 2019 | ||||
| Series B | May 1, 2017 | ||||
| Series A | Jun 1, 2015 |
For institutional investors. Book with your work email.
Pharmacodia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuan Ming Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 116% MoM.
- Mar 21, 2025
Monthly visitors increased 35% to 29.8K.
For institutional investors. Book with your work email.
Pharmacodia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pharmacodia's valuation, stock price, and market status.
Is Pharmacodia a public or private company?
Pharmacodia is a private company.
What is the current stock price of Pharmacodia?
Pharmacodia is a private company, so its shares have no public market price. Caplight tracks Pharmacodia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pharmacodia worth (valuation)?
Valuation information for Pharmacodia is not publicly available.
Can I buy Pharmacodia stock?
Pharmacodia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pharmacodia's last funding round?
Pharmacodia's most recent funding round was Series C on April 18, 2019.
Who are the main investors in Pharmacodia?
Key investors in Pharmacodia include Yuan Ming Capital.
Will Pharmacodia IPO soon?
No public IPO plans have been announced for Pharmacodia.
How can I track Pharmacodia secondary market activity?
Caplight tracks bids, offers, and trades in Pharmacodia's shares on secondary markets.